Abiopharma

🔍 Alfonso Humberto P (Director)

Company: EASTMAN CHEMICAL CO (EMN)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 1,628 shares of Phantom Stock Units (Derivative)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 57,588.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F1, F1, F1

Footnotes:

• F1: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash.
• F2: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock.